• Clinical Insights

February 2024 drug trend report

Feb 1st, 2024

Staying on top of new drug launches and shortages can be difficult. Read Genoa Healthcare’s latest drug trend report for an overview and connect with your local pharmacy team to learn more.

Brand name drug launches*

Exxua (Gepirone ER)

  • Indicated for: Treatment of major depressive disorder (MDD) in adults.
  • Dosage form: Oral extended-release tablets.
  • Status: Expected early 2024.

Generic drug launches*

Risperdal Consta® (Risperidone ER injectable powder kit)

  • Indicated for: Treatment of schizophrenia and other behavioral health conditions, such as bipolar disorder.
  • Dosage form: Long-acting injection.
  • Status: Available now.

Current drug shortages*


Advair Diskus 100/50, 250/50 and 500/50

  • Indicated for: Treatment of asthma and/or chronic obstructive pulmonary disease (COPD).
  • Status: Recovery TBD.

Zyprexa Relprevv

  • Indicated for: Treatment of schizophrenia in adults.
  • Status: Estimated recovery June 2024.


Buproprion XL

  • Indicated for: Treatment of depression.
  • Status: Recovery TBD.


  • Indicated for: Treatment of alcohol and/or opioid use disorder.
  • Status: Recovery TBD.

Lidocaine 5% patches

  • Indicated for: Localized pain control and/or postherpetic neuralgia.
  • Status: Recovery TBD.

*Information on this page was accurate at the time of posting. Shortage recovery dates are only estimates. These estimates are based on the distribution information that Genoa has access to.

Recent Posts

  • Blog Post
A foundation to build on: 3 ways an engaged pharmacy partner helps you deliver whole-person health

A recent survey found that nearly 60% of behavioral health, primary care and complex care providers reported that their organization currently offered or had plans to begin offering integrated care...

  • Blog Post
Genoa’s annual art celebration celebrates the healing power of art

Consumers can submit their artwork to Genoa’s celebration from June 1 – July 31. “Taking time to make art means taking time for myself,” says Genoa Healthcare® consumer MJ. For...

  • Blog Post
Partnering with ACT teams to make an even bigger impact

Genoa Healthcare® pharmacist Julie R. has seen firsthand the impact that severe and persistent mental illness can have on a person. For one of her consumers living with schizophrenia, the...

  • Blog Post
National Prevention Week: Genoa pharmacy teams put training into action to support consumers living with substance use disorder

When she heard a woman down the street from her pharmacy became unresponsive after using opioids, Genoa Healthcare® Pharmacist Kristen Pyland leveraged her training and quick thinking to help save...